Clinical Trials Sponsored by Rigel Dermatology

Total 1025 results

The Korean Society of Pediatric Hematology Oncology

Recruiting

Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children

Child | Acute Lymphoblastic Leukemia

Korea, Republic of
Takeda
The Organization of Teratology Information Specialists

Completed

OTIS Vedolizumab Pregnancy Exposure Registry

Crohn's Disease | Colitis, Ulcerative

United States
GlaxoSmithKline
The Organization of Teratology Information Specialists

Terminated

Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada

Infections, Papillomavirus

United States
Hematology and Oncology Associates of NE Pennsylvania

Completed

Study of the Therapeutic Use of Language in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
The Korean Society of Pediatric Hematology Oncology

Unknown

Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation

Pediatric Solid Tumor

Korea, Republic of
The Korean Society of Pediatric Hematology Oncology

Unknown

Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)

Anemia, Aplastic

Korea, Republic of
The Korean Society of Pediatric Hematology Oncology

Unknown

Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)

Aplastic Anemia

Korea, Republic of
The Korean Society of Pediatric Hematology Oncology

Unknown

Study of Reduced Toxicity Myeloablative Conditioning Regimen for Cord Blood Transplantation in Pediatric AML

Acute Myeloid Leukemia

Korea, Republic of
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Selinexor、Venetoclax and Azactidine in the Treatment of ND AML Patients Who Are Not Eligible for Intense Chemotherapy

Acute Myeloid Leukemia, Adult

China
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Acute Lymphoid Leukemia

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma

B Cell Lymphoma

China
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Elderly/Unfit Ph- B-ALL

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Detecting Minimal Residual Diseases (MRD) and Monitoring Clonal Evolution Using Ultrasensitive Chromosomal Aberrations Detection (UCAD) in Multiple Myeloma

Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia | Idiopathic Thrombocytopenic Purpura

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia | Treatment

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy

Thrombotic Microangiopathies | Hematopoietic Stem Cell Transplantation

China
Hematology Oncology Associates of Central New York

Not yet recruiting

PFA 100 Evaluation and Reference Interval HOACNY

Effect of Drug
Institute of Hematology & Blood Diseases Hospital...

Recruiting

The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Refractory/Relapsed Autoimmune Hemolytic Anemia

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma

Multiple Myeloma

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

A Study of VRd-based Regimen Combined With CART-ASCT-CART2 Treatment in NDMM Patients With P53 Abnormalities

Multiple Myeloma

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia

Essential Thrombocytopenia

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

Essential Thrombocytopenia

China
Institute of Hematology & Blood Diseases Hospital...

Recruiting

Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AML

AML

China
Institute of Hematology & Blood Diseases Hospital...

Terminated

Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment (BID-PERAL)

Acquired Pure Red Cell Aplasia

China
Center for Supporting Hematology-Oncology Trials
Bayer

Completed

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Febrile Neutropenia

Japan
University of Michigan Rogel Cancer Center
Novartis Pharmaceuticals

Terminated

Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer

Prostate Cancer

United States
University of Michigan Rogel Cancer Center
Augusta University

Withdrawn

Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations

Non-Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center
Genentech, Inc.

Terminated

Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

Loco-regional Esophageal Cancer
University of Michigan Rogel Cancer Center
Genentech, Inc.

Completed

UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer

HER-2 Positive Metastatic Breast Cancer

United States
University of Michigan Rogel Cancer Center
Genentech, Inc.

Not yet recruiting

A Proof of Concept Pilot Study of the Addition of Venetoclax to Standard Remission Induction Chemotherapy Fludarabine or Cladrabine, Cytarabine, and Granulocyte Colony Stimulating Factor (G-CSF) (FLAG or CLAG) for Frontline Therapy of Secondary Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia

United States
Bobbie Jo Rimel, MD

Recruiting

Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

Recurrent Ovarian Cancer | Platinum-sensitive Ovarian Cancer

United States
University of Michigan Rogel Cancer Center
NRG Oncology

Completed

An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors

Cancer-related Cognitive Impairment | Breast Cancer Survivorship

United States
University of Michigan Rogel Cancer Center
Amgen; Mallinckrodt

Completed

Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant

Graft Versus Host Disease

United States
University of Michigan Rogel Cancer Center
Celgene Corporation

Terminated

Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer

Bladder Cancer | Urothelial Cancer

United States
University of Michigan Rogel Cancer Center
Genentech, Inc.

Completed

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

Urologic Neoplasms

United States
Lynn Henry

Completed

A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy

Breast Cancer

United States
University of Michigan Rogel Cancer Center
Sanofi-Synthelabo

Completed

Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer

Pancreatic Neoplasms

United States
Lynn Henry

Completed

Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients

Pain | Breast Cancer

United States
Lynn Henry

Completed

Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms

Breast Cancer | Arthralgia

United States
University of Michigan Rogel Cancer Center
Celgene Corporation

Completed

Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer

Bladder Cancer

United States
Santalis Pharmaceuticals, Inc.
Derm Research, PLLC; ClinDatrix, Inc.; Texas Dermatology and Laser Specialists; Clinical Trials of Texas, Inc... and other collaborators

Completed

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis

Eczema | Atopic Dermatitis

United States
National Research Center for Hematology, Russia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology; DNKOM LLC

Completed

Validation of 'Corona-T-test' for Assessment of SARS-COV-2-specific T-cell Response After COVID-19 or Vaccination

SARS-CoV-2 Infection | SARS-CoV-2 Vaccination

Russian Federation
University Hospital Schleswig-Holstein
Dermatologic Cooperative Oncology Group

Completed

Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma (SoraPeg)

Melanoma

Germany
Shanghai Institute Of Biological Products
Chinese Academy of Medical Sciences Dermatology Hospital

Completed

A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster

Herpes Zoster

China
Fundación Academia Española de Dermatología
Roche Pharma AG

Completed

Spanish Registry of Mohs Surgery (REGESMOHS)

Melanoma | Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Skin Neoplasms | Histiocytoma, Malignant Fibrous | Dermatofibrosarcoma | Neoplasms, Adnexal and Skin Appendage

Spain
University Hospital, Strasbourg, France
Société de Dermatologie Française

Active, not recruiting

Borrelia Species in Cutaneous Lyme Borreliosis

Lyme Borreliosis

France
Centre de Pharmacologie Clinique Applique a la...

Completed

Protective Effect Assessment of Foto Ultra Isdin Solar Allergy Fusion Fluid on the UVA Induced PLE

Polymorphic Light Eruption

France
Massachusetts General Hospital
American Society for Dermatologic Surgery

Completed

Comparison of 1,550-nm Laser and Fractional Radiofrequency Microneedle for the Treatment of Acne Scars in Ethnic Skin

Acne Scars

United States
University of Utah
American Society for Dermatologic Surgery

Completed

308nm Excimer Laser for Treatment of Fingernail Psoriasis (NAPSI)

Nail Psoriasis

United States

Clinical Trials Sponsored by Rigel Dermatology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations